Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Hemoadsorption on Vascular Integrity in Septic Shock (ADSORP-VIP Trial): Protocol of a Prospective, Randomised, Controlled Trial

NCT07711197 is registered in ClinicalTrials.gov with Semmelweis University as lead sponsor.

NCT NCT07711197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07711197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Hemoadsorption on Vascular Integrity in Septic Shock (ADSORP-VIP Trial): Protocol of a Prospective, Randomised, Controlled Trial
Lead sponsor
Semmelweis University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
January 1, 2029
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock